Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial-Reference-Cited by-同舟云学术

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Published:2024-06-17 Issue: Volume: Page:
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Horwitz Steven M.^ORCID,Nirmal Ajit J.^ORCID,Rahman Jahan^ORCID,Xu Ran^ORCID,Drill Esther^ORCID,Galasso Natasha,Ganesan Nivetha,Davey Theresa,Hancock Helen,Perez Leslie,Maccaro Catherine,Bahgat Alexandra,Marzouk Evan,Cathcart Elizabeth,Moskowitz Alison,Noy Ariela,Kumar Anita,Jacobsen Eric,Fisher David C.^ORCID,Mehta-Shah Neha,Kim Youn H.,Khodadoust Michael,Kotlov Nikita^ORCID,Nikitina Anastasia,Kudryashova Olga^ORCID,Zubareva Valeria,Zornikova Ksenia,Shin Nara^ORCID,Sorokina Maria^ORCID,Degryse Sandrine,Postovalova Ekaterina^ORCID,Bagaev Aleksander,Hosszu Kinga^ORCID,McAvoy Devin,Boelens Jaap J.^ORCID,Wu Wenchao,Ciantra Zoe,Appelt Jackson W.,Trevisani Christopher^ORCID,Amaka Sam,Weinstock David M.^ORCID,Vardhana Santosha A.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41591-024-03076-6.pdf

Reference74 articles.

1. Leseux, L. et al. Syk-dependent mTOR activation in follicular lymphoma cells. Blood 108, 4156–4162 (2006).

2. Rudelius, M. et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108, 1668–1676 (2006).

3. Rassidakis, G. Z. et al. Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma. Blood 105, 827–829 (2005).

4. Uddin, S. et al. Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108, 4178–4186 (2006).

5. Slupianek, A. et al. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res. 61, 2194–2199 (2001).